Results 41 to 50 of about 60,530 (285)

Partial protective efficacy of the current licensed Japanese encephalitis live vaccine against the emerging genotype I Japanese encephalitis virus isolated from sheep. [PDF]

Front Immunol
Zhang H, Zhang Y, Li D, Zheng J, Zhang J, Li Z, Liu K, Li B, Shao D, Qiu Y, Ma Z, Wei J, Liu J.   +12 more
europepmc   +3 more sources

Forecasting median and mode dates of prevalence of Japanese encephalitis patients by electronic computer (epidemiological studies on Japanese encephalitis, 31) [PDF]

, 1970
For the purpose of forecasting the prevalence ofJapanese encephalitis in Japan, we tried to find out the correlation of factors between median and mode dates of epidemic time curve of prevalence on one hand, and average atmospheric temperatures of ...
Ogata, Masana, Osaki, Hirokazu
core   +1 more source

Clinical profile and outcome of acute encephalitis syndrome (AES) patients treated in College of Medical Sciences-Teaching Hospital

Journal of College of Medical Sciences-Nepal, 2014
Objective: Acute encephalitis syndrome is a cause of significant morbidity and mortality in Nepal. Although Japanese encephalitis virus (JEV) was thought to be a major cause for acute encephalitis syndrome, more non-Japanese encephalitis virus cases
Lekhjung J Thapa, RS Twayana, R Shilpakar, MR Ghimire, A Shrestha, S Sapkota, PVS Rana   +6 more
doaj   +1 more source

Japanese Encephalitis Complicated with Obstructive Hydrocephalus [PDF]

Journal of Clinical and Diagnostic Research, 2016
Japanese Encephalitis (JE), caused by Japanese encephalitis virus (JEV), a flavi-virus, is the most significant aetiology of arboviral encephalitis worldwide. It has resulted in epidemics of encephalitis in the Indian subcontinent.
Vivek Suman, Ujjawal Roy, Ajay Panwar, Alpana Raizada   +3 more
doaj   +1 more source

A Bibliometric Analysis of Global Research on Japanese Encephalitis From 1934 to 2020

Frontiers in Cellular and Infection Microbiology, 2022
Japanese encephalitis (JE) is a mosquito-borne disease caused by the Japanese encephalitis virus (JEV). The disease is mainly an epidemic in Asia and has been studied for nearly 90 years.
Chongxiao Xu, Weijia Zhang, Yuefeng Pan, Guowei Wang, Qikai Yin, Shihong Fu, Fan Li, Ying He, Songtao Xu, Zhenhai Wang, Guodong Liang, Kai Nie, Huanyu Wang, Huanyu Wang   +13 more
doaj   +1 more source

Clinical Spectrum and Outcomes of SOX1 Antibody‐Associated Paraneoplastic Neurological Syndromes: A Chinese Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background SOX1 antibody‐positive paraneoplastic neurological syndromes (PNS) exhibit significant population‐specific clinical heterogeneity. While Western cohorts predominantly manifest Lambert‐Eaton myasthenic syndrome (65%–80%), comprehensive clinical characterization and treatment response data in Asian populations remain critically ...
Jin‐Long Ye, Zu‐Ying Kuang, Bo Li, Meng‐Qiu Pan, Li‐Hua Zhou, Yang‐Yang Dai, Si‐Fen Xie, Xian‐Guang Lin, Ye‐Peng Hu, Li‐Hong Jiang, Zhan‐Hang Wang, Wei‐Jing Zhang   +11 more
wiley   +1 more source

Japanese encephalitis virus: An overview

Journal of Vector Borne Diseases
Japanese encephalitis (JE) is a mosquito-borne infectious disease caused by the Japanese encephalitis virus (JEV), posing a substantial threat to human health and property and safety.
Qiuyang Li, Xiaoling Cheng, Min Luo, Jinrong Shi   +3 more
doaj   +1 more source

Mixed Upper and Lower Motor Neuron Damage in Japanese Encephalitis Virus Infection

Case Reports in Neurology, 2020
Cerebral manifestations in Japanese B encephalitis are well known. However, there are very few studies focusing on extra-cerebral manifestations, among which focal anterior horn cell involvement is exceedingly rare.
Ritwik Ghosh, Souvik Dubey, Subhankar Chatterjee, Biman Kanti Ray, Julián Benito-León   +4 more
doaj   +1 more source

Nano‐ and Micro‐Sized Solid Materials Used as Antiviral Agents

Advanced Functional Materials, EarlyView.
Due to the rise of viral infections in humans and possible viral outbreaks, the use of nano‐ or micro‐sized materials as antiviral agents is rapidly increasing. This review explores their antiviral properties against RNA and DNA viruses, either as a prevention or a treatment tool, by delving into their mechanisms of action and how to properly assess ...
Orfeas‐Evangelos Plastiras, Imelda Raczkiewicz, Peggy Bouquet, Jean‐Philippe Dacquin, Jeremy Dhainaut, Anne Goffard, Christophe Volkringer   +6 more
wiley   +1 more source

Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins. [PDF]

, 2009
© 2009 Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited ...
Béatrice Nal, Joanne Lo, John M. Nicholls, Kevin Tsz Hin Kwok, Lewis Yu Lam Siu, Maciej Lesniak, Martin Sachse, Mateusz Kudelko, Pei-Gang Wang, Ralf M. Altmeyer, Roberto Bruzzone   +10 more
core   +8 more sources